Brandywine Global Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-116,763
Closed -$4.73M 851
2019
Q4
$4.73M Sell
116,763
-3,762
-3% -$140K 0.03% 413
2019
Q3
$4.18M Sell
120,525
-39,340
-25% -$1.3M 0.03% 422
2019
Q2
$5.07M Buy
159,865
+42,175
+36% +$1.25M 0.04% 409
2019
Q1
$3.52M Buy
+117,690
New +$3.37M 0.02% 448

Other funds holding PBH

Brandywine Global Investment Management's PBH Position: Q1 2020 in Review

Brandywine Global Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 116,763 shares — an estimated $4.73M sold.

Brandywine Global Investment Management first reported a position in PBH in Q1 2019 and held it in 4 quarters. The position peaked at $5.07M in Q2 2019. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • Brandywine Global Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
  • Brandywine Global Investment Management sold 116,763 Prestige Consumer Healthcare shares in Q1 2020, an estimated $4.73M.
  • Brandywine Global Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 4 quarters.
  • Brandywine Global Investment Management's Prestige Consumer Healthcare position peaked at $5.07M in Q2 2019.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Brandywine Global Investment Management's 13F filing for Q1 2020, filed 15 May 2020.